What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Trial name: PROTECT-Cog Study (Prevention of Risk fOr cogniTive dEcline through Combined Therapy) Sponsor: Alzheimer's Association Announced: July 13, 2026, at AAIC 2026, London Budget: $100 million Design: Global clinical trial
definitely recommend you pay them a visit
5 Borde-ChicheP.DiederichM.MorceauF.WellmanM.DicatoM
In 2013, Rafeek HidhayathBasha et al
Within months of insulins clinical introduction, investigators began experimenting with oral dosing, often administering vast quantities of crude pancreatic extracts to replicate the glucose-lowering effects observed with injection ( During the pioneering era from the 1920s through the 1950s, oral peptide delivery was pursued primarily through empirical experimentation
Research from the University of Copenhagen's circadian metabolism lab found that amylin's satiety effect was 22% stronger when administered in the late afternoon (4-6pm) compared to early morning (6-8am), independent of meal timing